Altiratinib |
ALTIRATINIB |
1345847-93-9 |
CYM50308 |
CYM50308 |
1345858-76-5 |
ethyl 5-chloro-1,2,4-thiadiazole-3-carboxylate |
ethyl 5-chloro-1,2,4-thiadiazole-3-carboxylate |
1346147-95-2 |
TP0903 |
TP-0903 |
1341200-45-0 |
6-amino-4-methoxy analogue of ZSTK474 (Compound 10w) |
化合物 COMPOUND 10W |
1336890-05-1 |
NG-25 |
N-[4-[(4-乙基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]-4-甲基-3-(1H-吡咯并[2,3-B]吡啶-4-基氧基)苯甲酰胺 |
1315355-93-1 |
TC-N 22A |
TC-N 22A |
1314140-00-5 |
LY-2940094 |
CS-2822 |
1307245-87-9 |
(S)-2-Hydroxy-2’-[(R)-hydroxy(phenyl)methyl]-[1,1’-binaphthalene] |
(S)-2-羟基-2'-[(R)-羟基(苯基)甲基]-[1,1'-联萘] |
1281985-73-6 |
(S)-2-Hydroxy-2’-[(R)-hydroxy(o-tolyl)methyl]-[1,1’-binaphthalene] |
(S)-2-羟基-2'-[(R)-羟基(邻甲苯基)甲基]-[1,1'-联萘] |
1281985-77-0 |
Isoquinoline, 6-[[(2R)-hexahydro-2-methyl-1,4-diazocin-1(2H)-yl]sulfonyl]- |
化合物 COTOSUDIL |
1258833-31-6 |
2H-1-Benzopyran-2-one, 3-[(2E)-3-(2-chlorophenyl)-1-oxo-2-propen-1-yl]- |
化合物 MAO-B-IN-2 |
1253978-24-3 |
Abemaciclib |
阿贝西利 |
1231929-97-7 |
MLN0905 |
2-[[5-[3-(二甲基氨基)丙基]-2-甲基-3-吡啶基]氨基]-5,7-二氢-9-(三氟甲基)- 6H-嘧啶并[5,4-D][1]苯并氮杂卓-6-硫酮 |
1228960-69-7 |
EsoMeprazole related substance H431/41 |
埃索美拉唑进口标准杂质H431/41 |
1227380-90-6 |
PF-06447475 |
PF-06447475 |
1527473-33-1 |
LOXO-101 (sulfate) |
(3S)-N-[5-[(2R)-2-(2,5-二氟苯基)-1-吡咯烷基]吡唑并[1,5-A]嘧啶-3-基]-3-羟基-1-吡咯烷甲酰胺硫酸盐 |
1223405-08-0 |
FX1 |
CS-2497 |
1426138-42-2 |
TC LPA5 4 |
TC LPA5 4 |
1393814-38-4 |
GSK J2 |
N-[2-(3-吡啶基)-6-(1,2,4,5-四氢-3H-3-苯并氮杂卓-3-基)-4-嘧啶基]-BETA-丙氨酸 |
1394854-52-4 |